Close
ACHEMA MIDDLE EAST 2026

ADCs: Innovations And Market Dynamics In Cancer Therapy

Antibody drug conjugates (ADCs) are the main players in the fields of cancer clinical research and deal-making, with new alliances and contracts appearing on...

Pharmaceutical Water Market: Expected $96.97B Growth By 2033

The pharmaceutical water market is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2034. It was valued...

Recursion, Exscientia Unite For $850M, 10 Trials In 18 Months

The resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over the next 18 months,...

AI Revolutionizes Drug Discovery And Development Process

The world is very interested in generative artificial intelligence (GAI), and for good reason. People have a better idea of what AI can do...

AI In Drug Development: Calls For Straightforward Regulation

A full-day training called Artificial Intelligence in Drug and Biological Product Development was held on August 6, 2024, by the Food and Drug Administration...

Scaling Cell And Gene Therapies: Challenges And Solutions

It is not always easy to go from novel research to a working business plan. There are still problems with prices and safety, as...

The Cell & Gene Therapy – From Innovation To Market Growth

In 2023, the market for cell and gene therapy was worth USD 18.8 billion. In the years to come, the market is projected to...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...